Vibrio parahaemolyticus orchestrates a multifaceted host cell infection by induction of autophagy, cell rounding, and then cell lysis.

PubWeight™: 1.49‹?› | Rank: Top 4%

🔗 View Article (PMC 2527940)

Published in Proc Natl Acad Sci U S A on August 19, 2008

Authors

Dara L Burdette1, Melanie L Yarbrough, Anthony Orvedahl, Christopher J Gilpin, Kim Orth

Author Affiliations

1: Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.

Articles citing this

Autophagy, immunity, and microbial adaptations. Cell Host Microbe (2009) 5.84

Eating the enemy within: autophagy in infectious diseases. Cell Death Differ (2008) 2.17

Outer membrane adhesion factor multivalent adhesion molecule 7 initiates host cell binding during infection by gram-negative pathogens. Proc Natl Acad Sci U S A (2011) 1.97

Vibrio parahaemolyticus cell biology and pathogenicity determinants. Microbes Infect (2011) 1.78

Vibrio parahaemolyticus: a review on the pathogenesis, prevalence, and advance molecular identification techniques. Front Microbiol (2014) 1.59

Contribution of Vibrio parahaemolyticus virulence factors to cytotoxicity, enterotoxicity, and lethality in mice. Infect Immun (2010) 1.57

Kinetic and structural insights into the mechanism of AMPylation by VopS Fic domain. J Biol Chem (2010) 1.51

Inflammation and disintegration of intestinal villi in an experimental model for Vibrio parahaemolyticus-induced diarrhea. PLoS Pathog (2012) 1.47

CRISPR/Cas9 Screens Reveal Requirements for Host Cell Sulfation and Fucosylation in Bacterial Type III Secretion System-Mediated Cytotoxicity. Cell Host Microbe (2016) 1.40

Vibrio VopQ induces PI3-kinase-independent autophagy and antagonizes phagocytosis. Mol Microbiol (2009) 1.22

A Vibrio parahaemolyticus T3SS effector mediates pathogenesis by independently enabling intestinal colonization and inhibiting TAK1 activation. Cell Rep (2013) 1.04

Development of two animal models to study the function of Vibrio parahaemolyticus type III secretion systems. Infect Immun (2010) 1.04

Characterization of Aeromonas hydrophila wound pathotypes by comparative genomic and functional analyses of virulence genes. MBio (2013) 1.02

Vibrio effector protein, VopQ, forms a lysosomal gated channel that disrupts host ion homeostasis and autophagic flux. Proc Natl Acad Sci U S A (2013) 0.96

The Vibrio parahaemolyticus Type III Secretion Systems manipulate host cell MAPK for critical steps in pathogenesis. BMC Microbiol (2010) 0.96

Vibrio parahaemolyticus infection induces modulation of IL-8 secretion through dual pathway via VP1680 in Caco-2 cells. J Infect Dis (2010) 0.96

Rapid identification of Vibrio parahaemolyticus by whole-cell matrix-assisted laser desorption ionization-time of flight mass spectrometry. Appl Environ Microbiol (2009) 0.96

Vp1659 is a Vibrio parahaemolyticus type III secretion system 1 protein that contributes to translocation of effector proteins needed to induce cytolysis, autophagy, and disruption of actin structure in HeLa cells. J Bacteriol (2010) 0.95

Fitness factors in vibrios: a mini-review. Microb Ecol (2013) 0.94

Not without cause: Vibrio parahaemolyticus induces acute autophagy and cell death. Autophagy (2009) 0.93

A cytotoxic type III secretion effector of Vibrio parahaemolyticus targets vacuolar H+-ATPase subunit c and ruptures host cell lysosomes. PLoS Pathog (2012) 0.93

Effectors of animal and plant pathogens use a common domain to bind host phosphoinositides. Nat Commun (2013) 0.93

Acanthamoeba castellanii promotes the survival of Vibrio parahaemolyticus. Appl Environ Microbiol (2008) 0.93

Regulation of type III secretion system 1 gene expression in Vibrio parahaemolyticus is dependent on interactions between ExsA, ExsC, and ExsD. Virulence (2010) 0.90

The pathogenesis, detection, and prevention of Vibrio parahaemolyticus. Front Microbiol (2015) 0.87

Insights into the environmental reservoir of pathogenic Vibrio parahaemolyticus using comparative genomics. Front Microbiol (2015) 0.87

Transcriptome analysis of Vibrio parahaemolyticus in type III secretion system 1 inducing conditions. Front Cell Infect Microbiol (2014) 0.86

Screening for a single-chain variable-fragment antibody that can effectively neutralize the cytotoxicity of the Vibrio parahaemolyticus thermolabile hemolysin. Appl Environ Microbiol (2012) 0.81

Intracellular Vibrio parahaemolyticus escapes the vacuole and establishes a replicative niche in the cytosol of epithelial cells. MBio (2014) 0.80

Vibrio parahaemolyticus ExsE is requisite for initial adhesion and subsequent type III secretion system 1-dependent autophagy in HeLa cells. Microbiology (2012) 0.79

A novel adhesive factor contributing to the virulence of Vibrio parahaemolyticus. Sci Rep (2015) 0.78

Structural and regulatory mutations in Vibrio parahaemolyticus type III secretion systems display variable effects on virulence. FEMS Microbiol Lett (2014) 0.76

VgrG2 of type VI secretion system 2 of Vibrio parahaemolyticus induces autophagy in macrophages. Front Microbiol (2015) 0.75

Vibrio parahaemolyticus strengthens their virulence through modulation of cellular reactive oxygen species in vitro. Front Cell Infect Microbiol (2014) 0.75

How Bacteria Subvert Animal Cell Structure and Function. Annu Rev Cell Dev Biol (2016) 0.75

Regulatory actions of ToxR and CalR on their own genes and type III secretion system 1 in Vibrio parahaemolyticus. Oncotarget (2017) 0.75

Articles cited by this

LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J (2000) 41.48

Autophagy in the pathogenesis of disease. Cell (2008) 34.68

Autophagy in cell death: an innocent convict? J Clin Invest (2005) 10.70

LC3, GABARAP and GATE16 localize to autophagosomal membrane depending on form-II formation. J Cell Sci (2004) 9.20

Distinct classes of phosphatidylinositol 3'-kinases are involved in signaling pathways that control macroautophagy in HT-29 cells. J Biol Chem (2000) 8.68

Unveiling the roles of autophagy in innate and adaptive immunity. Nat Rev Immunol (2007) 7.43

Toll-like receptor signalling in macrophages links the autophagy pathway to phagocytosis. Nature (2007) 7.21

Genome sequence of Vibrio parahaemolyticus: a pathogenic mechanism distinct from that of V cholerae. Lancet (2003) 6.95

Escape of intracellular Shigella from autophagy. Science (2004) 6.64

LC3 conjugation system in mammalian autophagy. Int J Biochem Cell Biol (2004) 6.34

Cholera and other vibrioses in the United States. N Engl J Med (1985) 5.17

Vibrio parahaemolyticus infections in the United States, 1973-1998. J Infect Dis (2000) 4.35

Cellular autophagy: surrender, avoidance and subversion by microorganisms. Nat Rev Microbiol (2004) 4.31

Caspase-1-dependent pore formation during pyroptosis leads to osmotic lysis of infected host macrophages. Cell Microbiol (2006) 3.44

Yersinia signals macrophages to undergo apoptosis and YopJ is necessary for this cell death. Proc Natl Acad Sci U S A (1997) 3.43

Salmonella induces macrophage death by caspase-1-dependent necrosis. Mol Microbiol (2000) 3.34

Process of protein transport by the type III secretion system. Microbiol Mol Biol Rev (2004) 3.31

Wortmannin, a potent and selective inhibitor of phosphatidylinositol-3-kinase. Cancer Res (1994) 3.22

Necrosis, a well-orchestrated form of cell demise: signalling cascades, important mediators and concomitant immune response. Biochim Biophys Acta (2006) 3.12

Functional characterization of two type III secretion systems of Vibrio parahaemolyticus. Infect Immun (2004) 2.92

Apoptosis and autophagy: regulatory connections between two supposedly different processes. Apoptosis (2008) 2.56

Protective role of autophagy against Vibrio cholerae cytolysin, a pore-forming toxin from V. cholerae. Proc Natl Acad Sci U S A (2007) 2.27

Arp2/3-independent assembly of actin by Vibrio type III effector VopL. Proc Natl Acad Sci U S A (2007) 2.05

Cytotoxicity and enterotoxicity of the thermostable direct hemolysin-deletion mutants of Vibrio parahaemolyticus. Microbiol Immunol (2004) 1.80

Inhibition of MAPK and NF-kappa B pathways is necessary for rapid apoptosis in macrophages infected with Yersinia. J Immunol (2005) 1.78

Identification of proteins secreted via Vibrio parahaemolyticus type III secretion system 1. Infect Immun (2006) 1.76

Internucleosomal DNA cleavage triggered by plasma membrane damage during necrotic cell death. Involvement of serine but not cysteine proteases. Am J Pathol (1997) 1.58

Functions of the Yersinia effector proteins in inhibiting host immune responses. Curr Opin Microbiol (2005) 1.57

A newly discovered post-translational modification--the acetylation of serine and threonine residues. Trends Biochem Sci (2007) 1.55

Yersinia controls type III effector delivery into host cells by modulating Rho activity. PLoS Pathog (2008) 1.40

VopA inhibits ATP binding by acetylating the catalytic loop of MAPK kinases. J Biol Chem (2007) 1.40

VP1686, a Vibrio type III secretion protein, induces toll-like receptor-independent apoptosis in macrophage through NF-kappaB inhibition. J Biol Chem (2006) 1.12

Articles by these authors

Yersinia YopJ acetylates and inhibits kinase activation by blocking phosphorylation. Science (2006) 4.71

AMPylation of Rho GTPases by Vibrio VopS disrupts effector binding and downstream signaling. Science (2008) 3.44

Cutting edge: Salmonella AvrA effector inhibits the key proinflammatory, anti-apoptotic NF-kappa B pathway. J Immunol (2002) 2.70

RalB and the exocyst mediate the cellular starvation response by direct activation of autophagosome assembly. Cell (2011) 2.34

Arp2/3-independent assembly of actin by Vibrio type III effector VopL. Proc Natl Acad Sci U S A (2007) 2.05

Xanthomonas type III effector XopD targets SUMO-conjugated proteins in planta. Mol Microbiol (2003) 1.97

Outer membrane adhesion factor multivalent adhesion molecule 7 initiates host cell binding during infection by gram-negative pathogens. Proc Natl Acad Sci U S A (2011) 1.97

Fido, a novel AMPylation domain common to fic, doc, and AvrB. PLoS One (2009) 1.92

SNARE-mediated lipid mixing depends on the physical state of the vesicles. Biophys J (2005) 1.91

Vibrio parahaemolyticus cell biology and pathogenicity determinants. Microbes Infect (2011) 1.78

A newly discovered post-translational modification--the acetylation of serine and threonine residues. Trends Biochem Sci (2007) 1.55

Yersinia outer proteins: Yops. Cell Microbiol (2007) 1.52

Kinetic and structural insights into the mechanism of AMPylation by VopS Fic domain. J Biol Chem (2010) 1.51

Genome sequence of enterovirus D68 from St. Louis, Missouri, USA. Emerg Infect Dis (2015) 1.49

Parasite-induced TH1 cells and intestinal dysbiosis cooperate in IFN-γ-dependent elimination of Paneth cells. Nat Immunol (2012) 1.41

Manipulation of host membranes by bacterial effectors. Nat Rev Microbiol (2011) 1.41

VopA inhibits ATP binding by acetylating the catalytic loop of MAPK kinases. J Biol Chem (2007) 1.40

Salmonella secreted factor L deubiquitinase of Salmonella typhimurium inhibits NF-kappaB, suppresses IkappaBalpha ubiquitination and modulates innate immune responses. J Immunol (2008) 1.36

Stroboscopic image capture: reducing the dose per frame by a factor of 30 does not prevent beam-induced specimen movement in paraffin. Ultramicroscopy (2006) 1.35

AMPylation: Something Old is New Again. Front Microbiol (2010) 1.29

Inhibition of MAPK signaling pathways by VopA from Vibrio parahaemolyticus. J Biol Chem (2004) 1.25

Vibrio VopQ induces PI3-kinase-independent autophagy and antagonizes phagocytosis. Mol Microbiol (2009) 1.22

Tipping the balance by manipulating post-translational modifications. Curr Opin Microbiol (2010) 1.22

Virulence determinants for Vibrio parahaemolyticus infection. Curr Opin Microbiol (2013) 1.20

Vibrio parahaemolyticus type VI secretion system 1 is activated in marine conditions to target bacteria, and is differentially regulated from system 2. PLoS One (2013) 1.18

A Vibrio effector protein is an inositol phosphatase and disrupts host cell membrane integrity. Science (2010) 1.16

Type III effector VopC mediates invasion for Vibrio species. Cell Rep (2012) 1.14

Manipulation of kinase signaling by bacterial pathogens. J Cell Biol (2011) 1.14

Hijacking of host cell IKK signalosomes by the transforming parasite Theileria. Science (2002) 1.13

HTLV-1-Tax and ICAM-1 act on T-cell signal pathways to polarize the microtubule-organizing center at the virological synapse. Blood (2009) 1.12

AopP, a type III effector protein of Aeromonas salmonicida, inhibits the NF-kappaB signalling pathway. Microbiology (2006) 1.11

Functional characterization of the interaction between bacterial adhesin multivalent adhesion molecule 7 (MAM7) protein and its host cell ligands. J Biol Chem (2011) 1.11

Structural analysis of Xanthomonas XopD provides insights into substrate specificity of ubiquitin-like protein proteases. J Biol Chem (2007) 1.08

Subversion of cell signaling by pathogens. Cold Spring Harb Perspect Biol (2012) 1.08

2007 Keystone Symposium on Autophagy in Health and Disease. Autophagy (2007) 1.07

Evolution of a signalling system that incorporates both redundancy and diversity: Arabidopsis SUMOylation. Biochem J (2006) 1.05

AMPylation is a new post-translational modiFICation. Nat Chem Biol (2009) 1.04

Turnabout is fair play: use of the bacterial Multivalent Adhesion Molecule 7 as an antimicrobial agent. Virulence (2012) 1.02

A chemical reporter for protein AMPylation. J Am Chem Soc (2011) 1.01

In vitro characterization of multivalent adhesion molecule 7-based inhibition of multidrug-resistant bacteria isolated from wounded military personnel. Virulence (2012) 0.99

Targeting the bacteria-host interface: strategies in anti-adhesion therapy. Virulence (2013) 0.97

Vibrio effector protein, VopQ, forms a lysosomal gated channel that disrupts host ion homeostasis and autophagic flux. Proc Natl Acad Sci U S A (2013) 0.96

Visual neurotransmission in Drosophila requires expression of Fic in glial capitate projections. Nat Neurosci (2012) 0.96

Yersinia effector YopJ inhibits yeast MAPK signaling pathways by an evolutionarily conserved mechanism. J Biol Chem (2002) 0.95

Not without cause: Vibrio parahaemolyticus induces acute autophagy and cell death. Autophagy (2009) 0.93

Structural requirements for Yersinia YopJ inhibition of MAP kinase pathways. PLoS One (2008) 0.93

Acanthamoeba castellanii promotes the survival of Vibrio parahaemolyticus. Appl Environ Microbiol (2008) 0.93

Characterization of AMPylation on threonine, serine, and tyrosine using mass spectrometry. J Am Soc Mass Spectrom (2011) 0.92

The role of type III secretion system 2 in Vibrio parahaemolyticus pathogenicity. J Microbiol (2012) 0.91

A MAM7 peptide-based inhibitor of Staphylococcus aureus adhesion does not interfere with in vitro host cell function. PLoS One (2013) 0.90

What pathogens have taught us about posttranslational modifications. Cell Host Microbe (2013) 0.89

Characterization of a rabbit polyclonal antibody against threonine-AMPylation. J Biotechnol (2010) 0.88

Inhibiting AMPylation: a novel screen to identify the first small molecule inhibitors of protein AMPylation. ACS Chem Biol (2013) 0.87

In vitro signaling by MAPK and NFkappaB pathways inhibited by Yersinia YopJ. Methods Enzymol (2008) 0.83

In vitro activation of the IkappaB kinase complex by human T-cell leukemia virus type-1 Tax. J Biol Chem (2008) 0.82

RhoA-inhibiting NSAIDs promote axonal myelination after spinal cord injury. Exp Neurol (2011) 0.81

The pore-forming bacterial effector, VopQ, halts autophagic turnover. Autophagy (2013) 0.80

Lost after translation: post-translational modifications by bacterial type III effectors. Curr Opin Microbiol (2013) 0.79

Subversion of the cytoskeleton by intracellular bacteria: lessons from Listeria, Salmonella and Vibrio. Cell Microbiol (2015) 0.77

De-AMPylation unmasked: modulation of host membrane trafficking. Sci Signal (2011) 0.77

Structural and regulatory mutations in Vibrio parahaemolyticus type III secretion systems display variable effects on virulence. FEMS Microbiol Lett (2014) 0.76

Microbiology. A protein pupylation paradigm. Science (2008) 0.75

Testing for N-methyl-D-aspartate receptor autoantibodies in clinical practice. Can J Neurol Sci (2019) 0.75

The elusive activity of the Yersinia protein kinase A kinase domain is revealed. Trends Microbiol (2007) 0.75

An interview with Kim Orth. Trends Biochem Sci (2013) 0.75